We are live on ! Find out more
BWP

Baldwin Wealth Partners Portfolio holdings

AUM $1.53B
1-Year Est. Return 28.5%
This Fund
S&P 500
This Quarter Est. Return
-14.79%
1 Year Est. Return
+28.5%
3 Year Est. Return
+85.86%
5 Year Est. Return
+102.78%
10 Year Est. Return
+445.81%
AUM
$771M
AUM Growth
-$172M
Cap. Flow
-$20.9M
Cap. Flow %
-2.7%
Top 10 Hldgs %
41.51%
Holding
717
New
45
Increased
54
Reduced
142
Closed
19

Top Buys

Rank Stock Value
1
URI icon
United Rentals
URI
+$7.36M
2
KLAC icon
KLA
KLAC
+$6.17M
3
HON icon
Honeywell
HON
+$2.02M
4
NVCT icon
Nuvectis Pharma
NVCT
+$1.5M
5
IAU icon
iShares Gold Trust
IAU
+$1.34M

Sector Composition

Rank Sector Weight
1 Technology 20.93%
2 Financials 13.14%
3 Healthcare 12.62%
4 Communication Services 9.28%
5 Consumer Staples 8.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PUBM icon
451
PubMatic
PUBM
$633M
$24K ﹤0.01%
1,500
ATOM icon
452
Atomera
ATOM
$219M
$23K ﹤0.01%
2,469
DCBO
453
Docebo
DCBO
$523M
$23K ﹤0.01%
800
DVY icon
454
iShares Select Dividend ETF
DVY
$23.8B
$23K ﹤0.01%
197
EFG icon
455
iShares MSCI EAFE Growth ETF
EFG
$17B
$23K ﹤0.01%
290
ES icon
456
Eversource Energy
ES
$27.3B
$23K ﹤0.01%
269
MLPX icon
457
Global X MLP & Energy Infrastructure ETF
MLPX
$3.59B
$23K ﹤0.01%
600
STT icon
458
State Street
STT
$50.9B
$23K ﹤0.01%
373
XRAY icon
459
Dentsply Sirona
XRAY
$2.86B
$23K ﹤0.01%
635
BNY
460
Bank of New York Mellon
BNY
$106B
$22K ﹤0.01%
516
ENPH icon
461
Enphase Energy
ENPH
$5.52B
$22K ﹤0.01%
115
XRN
462
Chiron Real Estate Inc
XRN
$465M
$22K ﹤0.01%
400
PGX icon
463
Invesco Preferred ETF
PGX
$3.81B
$22K ﹤0.01%
1,767
QCOM icon
464
Qualcomm
QCOM
$171B
$22K ﹤0.01%
173
RXRX icon
465
Recursion Pharmaceuticals
RXRX
$1.76B
$22K ﹤0.01%
+2,751
New +$18.4K
ERNA icon
466
Eterna Therapeutics
ERNA
$5.16M
$21K ﹤0.01%
5
KEX icon
467
Kirby Corp
KEX
$7.08B
$21K ﹤0.01%
350
NUBD icon
468
Nuveen ESG US Aggregate Bond ETF
NUBD
$465M
$21K ﹤0.01%
900
VRTX icon
469
Vertex Pharmaceuticals
VRTX
$121B
$21K ﹤0.01%
75
WBA
470
DELISTED
Walgreens Boots Alliance
WBA
$21K ﹤0.01%
560
AZN icon
471
AstraZeneca
AZN
$241B
$20K ﹤0.01%
150
HAE icon
472
Haemonetics
HAE
$3.88B
$20K ﹤0.01%
301
-94
-24% -$5.56K
LBTYK icon
473
Liberty Global Class C
LBTYK
$3.6B
$20K ﹤0.01%
920
RMD icon
474
ResMed
RMD
$32.4B
$20K ﹤0.01%
97
SCZ icon
475
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.5B
$20K ﹤0.01%
366

Similar funds

Baldwin Wealth Partners's Q2 2022 Portfolio in Review

As of Q2 2022, Baldwin Wealth Partners held 717 positions worth $771M, down 18% from $944M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Baldwin Wealth Partners's Q2 2022 filing shows 45 new, 54 increased, 142 reduced and 19 closed positions. Its largest new stake was Nuvectis Pharma: 121,000 shares worth $1.35M. The largest sale was PayPal, an estimated $9.12M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.

  • Baldwin Wealth Partners's largest Q2 2022 buy was Nuvectis Pharma: 121,000 shares worth $1.35M.
  • Baldwin Wealth Partners added most to United Rentals in Q2 2022, an estimated $7.36M increase.
  • Baldwin Wealth Partners's biggest Q2 2022 reduction was PayPal, cutting an estimated $9.12M.
  • Baldwin Wealth Partners fully exited AMERICA FIRST TAX EXEMT INV LP in Q2 2022, selling an estimated $76K.
  • Baldwin Wealth Partners's ten largest holdings make up 42% of its $771M portfolio in Q2 2022.
  • Baldwin Wealth Partners opened 45 new positions and closed 19 in Q2 2022.
  • Baldwin Wealth Partners's portfolio value fell 18% quarter-over-quarter to $771M.

Based on Baldwin Wealth Partners's 13F filing for Q2 2022, filed 18 Jul 2022.